Portola Pharmaceuticals to Announce Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, August 9
02 Août 2017 - 2:00PM
Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) announced today that
it will host a webcast and conference call to discuss the Company’s
financial results for the quarter ended June 30, 2017, and provide
a general business overview on Wednesday, August 9, 2017, at 4:30
p.m. ET (1:30 p.m. PT).
Conference Call DetailsThe live conference call
on Wednesday, August 9, 2017, at 4:30 p.m. Eastern Time, can be
accessed by phone by calling (844) 452-6828 from the United States
and Canada or 1 (765)-507-2588 internationally and using the
passcode 61767329. The webcast can be accessed live on the Investor
Relations section of the Company's website at
http://investors.portola.com. It will be archived for 30 days
following the call.
About Portola Pharmaceuticals, Inc.
Portola Pharmaceuticals is a
biopharmaceutical company developing product candidates that could
significantly advance the fields of thrombosis and other
hematologic diseases. The Company’s first medicine
Bevyxxa® (betrixaban), an oral, once-daily Factor
Xa inhibitor, was approved by the U.S. Food and Drug Administration
in June 2017. The company is also working to advance two clinical
programs for andexanet alfa, a recombinant protein designed to
reverse the anticoagulant effect in patients treated with an oral
or injectable Factor Xa inhibitor; and cerdulatinib, a SYK/JAK
inhibitor in development to treat hematologic cancers. Portola's
partnered program is focused on developing selective SYK inhibitors
for inflammatory conditions. For more information,
visit http://www.portola.com and follow the Company on Twitter
@Portola_Pharma.
Investor Contact:
Mardi Dier, CFO
Portola Pharmaceuticals
IR@portola.com
Media Contact:
Julie Normart
Pure Communications
jnormart@purecommunications.com
415.946.1087
Portola Pharmaceuticals (NASDAQ:PTLA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Portola Pharmaceuticals (NASDAQ:PTLA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
Real-Time news about Portola Pharmaceuticals Inc (NASDAQ): 0 recent articles
Plus d'articles sur